Showing results (51-60 of 114) with videos related to
Sort By:
Pageof 12
European Journal of Applied Physiology|June 22, 2021
A biomarker perspective on the acute effect of exercise with and without impact on joint tissue turnover: an exploratory randomized cross-over studyJonathan J Bjerre-Bastos, Henning Bay Nielsen, Jeppe R Andersen, et al.Matrix Biology : Journal of the International Society for Matrix Biology|November 11, 2017
Inducible knockdown of procollagen I protects mice from liver fibrosis and leads to dysregulated matrix genes and attenuated inflammationOlena Molokanova, Kai Schönig, Shih-Yen Weng, et al.Scientific Reports|January 8, 2025
Regulation of fibronectin and collagens type I, III and VI by TNF-α, TGF-β, IL-13, and tofacitinibFrederik S Gillesberg, Martin Pehrsson, Anne-Christine Bay-Jensen, et al.Osteoarthritis and Cartilage Open|December 7, 2022
Evaluation of serum ARGS neoepitope as an osteoarthritis biomarker using a standardized model for exercise-induced cartilage extra cellular matrix turnoverJonathan J Bjerre-Bastos, Henning Bay Nielsen, Jeppe R Andersen, et al.Journal of Thrombosis and Haemostasis : JTH|September 17, 2023
Evaluation of collagen turnover biomarkers as an objective measure for efficacy of treatment with rurioctocog alfa pegol in patients with hemophilia A: a secondary analysis of a randomized controlled trialTina Manon-Jensen, Srilatha Tangada, Cecilie Bager, et al.Arthritis Research & Therapy|June 23, 2022
Extracellular matrix protein turnover markers are associated with axial spondyloarthritis-a comparison with postpartum women and other non-axial spondyloarthritis controls with or without back painHelena Port, Signe Holm Nielsen, Sofie Falkenløve Madsen, et al.JHEP Reports : Innovation in Hepatology|March 3, 2023
Effect of pegbelfermin on NASH and fibrosis-related biomarkers and correlation with histological response in the FALCON 1 trialElizabeth A Brown, Anne Minnich, Arun J Sanyal, et al.European Journal of Preventive Cardiology|February 14, 2018
Accelerated collagen turnover in women with angina pectoris without obstructive coronary artery disease: An iPOWER substudySigne H Nielsen, Naja D Mygind, Marie M Michelsen, et al.Hepatology (Baltimore, Md.)|October 4, 2021
BMS-986263 in patients with advanced hepatic fibrosis: 36-week results from a randomized, placebo-controlled phase 2 trialEric J Lawitz, Diane E Shevell, Giridhar S Tirucherai, et al.Cells|August 13, 2025
The Calprotectin Fragment, CPa9-HNE, Is a Plasma Biomarker of Mild Chronic Obstructive Pulmonary DiseaseMugdha M Joglekar, Jannie M B Sand, Theo Borghuis, et al.Pageof 12